LONP2
Lon protease homolog 2, peroxisomal
Also known as: LONP, LONP2_HUMAN, LONPL, MGC4840
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86WA8
- Gene
- LONP2
- Ensembl
- ENSG00000102910
- Chromosome
- 16
- Canonical length
- 852 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
In human, peroxisomes function primarily to catalyze fatty acid beta-oxidation and, as a by-product, produce hydrogen peroxide and superoxide. The protein encoded by this gene is an ATP-dependent protease that likely plays a role in maintaining overall peroxisome homeostasis as well as proteolytically degrading peroxisomal proteins damaged by oxidation. The protein has an N-terminal Lon N substrate recognition domain, an ATPase domain, a proteolytic domain, and, in some isoforms, a C-terminal peroxisome targeting sequence. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
852 residues, UniProt reviewed canonical sequence.
>Q86WA8|LONP2
1 MSSVSPIQIP SRLPLLLTHE GVLLPGSTMR TSVDSARNLQ LVRSRLLKGT SLQSTILGVI
61 PNTPDPASDA QDLPPLHRIG TAALAVQVVG SNWPKPHYTL LITGLCRFQI VQVLKEKPYP
121 IAEVEQLDRL EEFPNTCKMR EELGELSEQF YKYAVQLVEM LDMSVPAVAK LRRLLDSLPR
181 EALPDILTSI IRTSNKEKLQ ILDAVSLEER FKMTIPLLVR QIEGLKLLQK TRKPKQDDDK
241 RVIAIRPIRR ITHISGTLED EDEDEDNDDI VMLEKKIRTS SMPEQAHKVC VKEIKRLKKM
301 PQSMPEYALT RNYLELMVEL PWNKSTTDRL DIRAARILLD NDHYAMEKLK KRVLEYLAVR
361 QLKNNLKGPI LCFVGPPGVG KTSVGRSVAK TLGREFHRIA LGGVCDQSDI RGHRRTYVGS
421 MPGRIINGLK TVGVNNPVFL LDEVDKLGKS LQGDPAAALL EVLDPEQNHN FTDHYLNVAF
481 DLSQVLFIAT ANTTATIPAA LLDRMEIIQV PGYTQEEKIE IAHRHLIPKQ LEQHGLTPQQ
541 IQIPQVTTLD IITRYTREAG VRSLDRKLGA ICRAVAVKVA EGQHKEAKLD RSDVTEREGC
601 REHILEDEKP ESISDTTDLA LPPEMPILID FHALKDILGP PMYEMEVSQR LSQPGVAIGL
661 AWTPLGGEIM FVEASRMDGE GQLTLTGQLG DVMKESAHLA ISWLRSNAKK YQLTNAFGSF
721 DLLDNTDIHL HFPAGAVTKD GPSAGVTIVT CLASLFSGRL VRSDVAMTGE ITLRGLVLPV
781 GGIKDKVLAA HRAGLKQVII PRRNEKDLEG IPGNVRQDLS FVTASCLDEV LNAAFDGGFT
841 VKTRPGLLNS KLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LONP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- liver: 81 nTPM
- breast: 43 nTPM
- retina: 36 nTPM
- parathyroid gland: 36 nTPM
- thyroid gland: 30 nTPM
- prostate: 28 nTPM
Single-cell type
- pituicytes/fscs: 463 nCPM
- hepatocytes: 453 nCPM
- choroid plexus epithelial cells: 323 nCPM
- prostatic glandular cells: 311 nCPM
- lactotrophs: 289 nCPM
- retinal pigment epithelial cells: 286 nCPM
Immune cell
- memory CD4 T-cell: 13 nTPM
- non-classical monocyte: 13 nTPM
- naive CD4 T-cell: 12 nTPM
- intermediate monocyte: 12 nTPM
- naive B-cell: 12 nTPM
- classical monocyte: 12 nTPM
Brain region
- choroid plexus: 60 nTPM
- hippocampal formation: 49 nTPM
- cerebellum: 49 nTPM
- white matter: 49 nTPM
- basal ganglia: 49 nTPM
- medulla oblongata: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- peroxisome organization
- protein import into peroxisome matrix
- protein processing
- protein quality control for misfolded or incompletely synthesized proteins
- protein targeting to peroxisome
- regulation of fatty acid beta-oxidation
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATP-dependent peptidase activity
- enzyme binding
- peptidase activity
- protease binding
- serine-type endopeptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lon protease, N-terminal domain
- AAA+ ATPase domain
- ATPase, AAA-type, core
- Lon protease, bacterial/eukaryotic-type
- Peptidase S16, active site
- Peptidase S16, Lon proteolytic domain
- Small ribosomal subunit protein uS5 domain 2-type fold, subgroup
- PUA-like superfamily
- Ribosomal protein uS5 domain 2-type superfamily
- Lon protease
- P-loop containing nucleoside triphosphate hydrolase
- Lon protease, N-terminal domain superfamily
- Lon protease, AAA+ ATPase lid domain
- ATPase family associated with various cellular activities (AAA)
- ATP-dependent protease La (LON) substrate-binding domain
- Lon protease (S16) C-terminal proteolytic domain
- Lon protease AAA+ ATPase lid domain
- Lon protease homologue 2, peroxisomal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LONP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LONP2 as an antibody target. Whether an autoantibody or antibody against LONP2 could matter depends on whether native LONP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LONP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LONP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...